Novo Nordisk's weight loss drug, Wegovy, has received FDA approval for reducing the risk of major cardiovascular adverse events.Wegovy demonstrated a 20% reduction in the risk of major cardiovascular ...
Source LinkNovo Nordisk's weight loss drug, Wegovy, has received FDA approval for reducing the risk of major cardiovascular adverse events.Wegovy demonstrated a 20% reduction in the risk of major cardiovascular ...
Source Link
Comments